Join BOPA
Back to news articles

Pharmaceutical Journal Podcast (#PJPod)

By BOPA Committee on 27th October 2023

There are significant side effects and drug interactions associated with the use of Bruton tyrosine kinase (BTK) inhibitors. This episode of The #PJPod considers the impact these medicines have had on care for patients with B-cell malignancies, by hearing directly from an expert patient before exploring how pharmacists can help patients get the best out of their treatment regimens.

Listen here: https://pharmaceutical-journal.com/article/feature/btk-inhibitors-what-pharmacists-need-to-know

*Supported by BeiGene UK*

 

Latest News

By Joseph Williams on 30th April 2024

Pharmacists’ Essential Guide to Haematology – UCLH Cancer Academy

UCLH Cancer Academy would like to invite you to an educational program designed to help pharmacists’ understanding of malignant haematology. SACT-accredited pharmacists who are new to haematology or wish to…

Read article
By BOPA Committee on 30th April 2024

BOPA Passport and UTIC

Over the next few days we will rolling out an update to the current Passport content based on user feedback and errors highlighted. This includes updates to MCQs and a…

Read article
By BOPA Committee on 30th April 2024

Understanding targeted therapies and immunotherapies for cancer (UTIC)- learning course now available

ISOPP (The International Society of Oncology Pharmacy Practitioners) and BOPA (The British Oncology Pharmacy Association) are pleased to announce this joint collaboration project – UTIC (Understanding targeted therapies and immunotherapies…

Read article
By BOPA Committee on 30th April 2024

Clinical Pharmacy Congress Awards 2024

BOPA and Netty Cracknell have been shortlisted for the CPC 2024 awards!  For more information please the following website: CPC AWARDS 2024 SHORTLIST – Clinical Pharmacy Congress  

Read article